Inhibition of Plk1 Attenuates Downregulation of Water and Sodium Transporters in Obstructive Nephropathy
Kidney Diseases · 11.05.2026 · 12 (1) · 539-553
DOI: 10.1159/000552479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Diseases, online erschienen am 11.05.2026. Verfasst von Mengyu Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Obstructive nephropathy is frequently associated with downregulation of key renal water and sodium transporters, resulting in impaired urinary concentration and disrupted fluid balance. The present study aimed to investigate the role of Polo-like kinase 1 (Plk1), a kinase traditionally recognized for its function in cell-cycle regulation, in modulating renal water and sodium transporters in a unilateral ureteral obstruction (UUO) model, and to elucidate the underlying molecular mechanisms.
Methods
Plk1 function was inhibited pharmacologically using BI6727 or genetically using heterozygous Plk1 knockout mice. In vitro, renal collecting duct M1 cells were stimulated with TGF-β to examine mechanistic pathways.
Results
Inhibition of Plk1 with BI6727 preserved the expression of aquaporin 2 (AQP2) and sodium-potassium-chloride cotransporter 2 (NKCC2) in UUO kidneys. Similarly, heterozygous Plk1 knockout mice exhibited higher AQP2 and NKCC2 levels than wild-type controls. Mechanistically, Plk1 regulated cytosolic phospholipase A2 (cPLA2) activity, leading to elevated prostaglandin E2 (PGE2) production. PGE2 subsequently upregulated the E3 ubiquitin ligases NEDD4 and NEDD4L, promoting ubiquitin-proteasome-mediated degradation of AQP2 and NKCC2.
Conclusion
These findings indicate that Plk1 contributes to the maladaptive downregulation of renal water and sodium transporters during obstruction. Pharmacological inhibition or genetic reduction of Plk1 preserves transporter expression, highlighting the Plk1-cPLA2-PGE2-NEDD4/NEDD4L axis as a potential therapeutic target for correcting water and sodium imbalance in obstructive nephropathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
- Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China.
- Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zitieren
APA
Zhou, M., Cao, W., Lin, X., Tang, X., Huang, S., Jia, Z., Zhang, Y., Zhang, A., & Du, Y. (2026). Inhibition of Plk1 Attenuates Downregulation of Water and Sodium Transporters in Obstructive Nephropathy. Kidney Diseases, 12(1), 539-553. https://doi.org/10.1159/000552479
Vancouver
Zhou M, Cao W, Lin X, Tang X, Huang S, Jia Z, et al. Inhibition of Plk1 Attenuates Downregulation of Water and Sodium Transporters in Obstructive Nephropathy. Kidney Diseases. 2026;12(1):539-553. doi:10.1159/000552479
BibTeX
@article{Zhou2026,
author = {Zhou, Mengyu and Cao, Weidong and Lin, Xiuli and Tang, Xiaomei and Huang, Songming and Jia, Zhanjun and Zhang, Yue and Zhang, Aihua and Du, Yang},
title = {Inhibition of Plk1 Attenuates Downregulation of Water and Sodium Transporters in Obstructive Nephropathy},
journal = {Kidney Diseases},
year = {2026},
volume = {12},
number = {1},
pages = {539--553},
doi = {10.1159/000552479}
}
EUVIMED